Description
Sulindacisanon-steroidalanti-inflammatorydrug(NSAID)thatinhibitsCOX-1andCOX-2.Sulindacexhibitsanti-inflammatory,neuroprotective,anti-metastatic,andanticancerchemotherapeuticactivities.Invitro,sulindacinhibitsphosphodiesterases(PDEs),increasinglevelsofcGMPandactivationofPKGandinhibitingexpressionofβ-catenin.Inanimalmodelsofischemicstroke,sulindacdecreasesinfarctsizeandincreasesexpressionofAkt,Bcl-2,andHSP27.ThiscompoundinhibitsinvasionofbreastcancercellsandcoloncancercellsbydecreasingNF-κB-mediatedtranscriptionofseveralmiRNAs.Additionally,sulindacdownregulatesexpressionofSTAT3andsurvivinanddecreasescellproliferationandtumorgrowthincellularandanimalmodelsoflaryngealcancer.